Burlingame, CA, June 18, 2025 (GLOBE NEWSWIRE) — The global Geriatric Medicines Market is estimated to be valued at USD 1,073.13 Bn in 2025 and is expected to reach USD 1,701.91 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032. The global geriatric population key consumers of medications for age-related conditions is expanding rapidly. This growing demographic, often affected by multiple co-morbidities, is a major driver of demand for geriatric medicines. Additionally, the increasing focus of pharmaceutical companies on developing specialized treatments for elderly care is further fueling market growth. However, the widespread availability of generic drugs may pose a challenge to market expansion during the forecast period.
Get a Sample Pages of Geriatric Medicines Market@ https://www.coherentmarketinsights.com/insight/request-sample/6864
Global Geriatric Medicines Market Key Takeaways
According to Coherent Market Insights (CMI), the global geriatric medicines market size is anticipated to increase at a CAGR of 6.8%, reaching USD 1,073.13 Bn in 2025 and USD 1,701.91 Bn by 2032.
By disease indication, oncology segment is projected to account for more than one-fourth of the global geriatric medicines market share in 2025.
Based on form, tablet category will likely account for about USD 411 Bn by 2025.
In terms of route of administration, oral segment is expected to generate a revenue of about USD 613.83 Bn in 2025.
North America geriatric medicines market is estimated to be valued at around USD 393.83 Bn by 2025.
As per CMIs’ new geriatric medicines market analysis, Asia Pacific is poised to witness fastest growth throughout the assessment period.
Increasing Geriatric Population Spearheading Market Growth
Coherent Market Insights in its latest geriatric medicines market research report outlines major factors driving market growth. One such prominent growth factor is the increasing geriatric population globally.
People worldwide are living longer, leading to a spike in the overall geriatric population. According to the World Health Organization (WHO), one in six people globally will be aged 60 years or older by 2030.
Rise in the elderly population will create a strong demand for geriatric medicines. This is because older people are more susceptible to chronic disease and age-related disorders.
Buy This Premium Research Report at 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/6864
High Cost of Geriatric Drugs Restraining Market Growth
The prospective geriatric medicine market outlook looks promising, owing to increasing geriatric population and growing prevalence of chronic diseases. However, high cost of geriatric medications continues to be a significant barrier to broader market growth.
Many geriatric drugs, especially those addressing chronic and complex age-related conditions like Alzheimer’s, osteoporosis, and Parkinson’s, are expensive. This limits their affordability, particularly in low- and middle-income nations, thereby reducing overall geriatric medicines market demand.
Rising Prevalence of Chronic Diseases Creating Growth Avenues
The increasing incidence of chronic diseases such as arthritis, diabetes, Alzheimer’s, osteoporosis, and Parkinson’s among the elderly is driving demand for geriatric medicines. These conditions typically require long-term treatment, creating …